Validation of Algorithms Using ICD-10 Clinical Modification (CM) Codes in Claims Data to Identify People With Viral Hepatitis

Ming-Jen Sheu,Tsung-Wei Chin,Fang-Ping Ku,Chung-Yi Li,Sen-Tung Li,Tsung-Hsueh Lu
DOI: https://doi.org/10.21203/rs.3.rs-917019/v1
2021-10-11
Abstract:Abstract Background: The ICD-9 Clinical Modification (ICD‐9‐CM) coding system was transited into the ICD-10‐CM on October 1, 2015, in the United States and on January 1, 2016, in Taiwan. Little is known on the performance of various algorithms using ICD-10-CM codes in claims data to identify people with hepatitis B virus (HBV) and hepatitis C virus (HCV). Methods: A proportional systemic sampling of 10,000 patients aged ≥20 years in a health care system in Southern Taiwan were enrolled as study participants. According to the reference standards we confirmed 736 and 555 participants had HBV and HCV, respectively. Results: The algorithms with higher number of outpatient (OP) visits with ICD codes had higher positive predictive value (PPV); for example, the PPV for HBV using algorithm 1 (≥1 OP codes) was 72% and 86% according to ICD-9-CM and ICD-10-CM, respectively, and that of algorithm 3 (≥3 OP codes) was 80% and 90%, respectively. Similarly, the PPV for HCV using algorithm 1 was 88% and 96%, respectively, and using algorithm 3 was 93% and 99%, respectively. However, the algorithms with higher PPV complemented with lower sensitivity. Conclusions: In conclusion, algorithms using ICD-10-CM codes had better performance than those using ICD-9-CM codes in identifying people with HBV and HCV. Considering the tradeoff between PPV and sensitivity, the optimal algorithm is ≥2 OP visits or ≥1 inpatient visits with HBV or HCV ICD codes.
What problem does this paper attempt to address?